We are looking for a Patent Analyst with a focus in Mechanical Engineering or Medical Devices to join our team! This is an amazing opportunity to put your technical knowledge to use by researching and analyzing cutting edge technologies at Clarivate.

Work with us as a remote independent contractor in this flexible 1099 role supporting our contract with the US Patent & Trademark Office (USPTO). Our team has supported the USPTO by providing PCT Chapter I Search and Examination services since 2005. As an independent contractor, you will be responsible for performing a comprehensive search and a written opinion on the patentability of an array of diverse technologies. If selected, they will be expected to perform the work in accordance with the terms of a consulting agreement to be presented to them for consideration by Clarivate

About You – experience, education, skills, and accomplishments

U.S. citizen or work eligible legal resident who has resided in the U.S. for the last two years
Bachelor's degree in Mechanical Engineering, Biomedical Engineering, Life Sciences, or related field
1+ year of experience working with patents or in the intellectual property field
1+ year of work experience in the industry or advanced research in a related field
Must pass USPTO Background check
Ability to obtain a Public Trust Clearance

It would be great if you also had . . .

Previous patent examining/patent searching experience
Highly skilled developing a search methodology and conducting searches.
Strong time management skills and the ability to complete projects against deadlines.
Experience with Orbit, PatBase, Google Scholar or PatSeer
Master's degree or PhD is a plus

What will you be doing in this role?

On a weekly basis, accept projects with a defined due date based on your availability and the needs of Clarivate.
Demonstrate the ability to read a disclosure quickly and understand the technical nuances which may potentially distinguish it from the prior art.
Perform a comprehensive search to ensure the most relevant prior art is located and provide a logical and complete search history.
Prepare a written opinion applying the most relevant prior art to the disclosure.
Maintain proficiency with commercial patent searching databases and other proprietary databases of technical publications.
Stay abreast of best practices and changes to search procedures via self-directed review of materials provided by Clarivate.
Maintain consistent timeliness and superior quality of deliverables.
Ensure compliance with Clarivate’s Code of Business Ethics and Corporate Conduct

Required Equipment for the job:

A computer running up to date versions of Windows or Mac OS
Reliable, High Speed Internet connection: at least 10 Mbps of download speed and 1 Mbps of upload speed of dedicated internet bandwidth
Secure work location, working from public areas is not permitted
Phone and voicemail service for business communication

Hours of Work

Flexible work hours
This is a remote position, but all work must be completed in the United States

Compensation - US Only

The expected pay for this position is based on productivity. The expected pay is $475 per patent case completed.  Individual pay is based upon experience, education, skill and ability, expertise, and relevant factors.

#LI-Remote

#LI-LP

At Clarivate, we are committed to providing equal employment opportunities for all qualified persons with respect to hiring, compensation, promotion, training, and other terms, conditions, and privileges of employment. We comply with applicable laws and regulations governing non-discrimination in all locations.

About the company

Clarivate provides subscription-based analytics platforms and services focused on bibliometrics, scientometrics, business and patent intelligence, and regulatory standards for researchers, organizations, and regulators. Its products, including Web of Science and Derwent World Patents Index, give access to citation and patent data through a subscription model, enabling users to search, analyze, and generate reports. It stands out by offering an integrated suite that spans academia, intellectual property, and regulatory domains, backed by long-standing, curated data and trusted brands. The goal is to help organizations accelerate innovation and protect and manage their intellectual assets through reliable data, analytics, and regulatory intelligence.

Company Size

10,001+

Company Stage

IPO

Headquarters

London, United Kingdom

Founded

2016

Get referred to Clarivate

See people who can refer or advise you

Simplify's Take

What believers are saying

The July 2026 Altaris sale of Life Sciences & Healthcare lifts recurring mix toward 92%.
Q2 2026 adjusted EPS hit $0.19, beating estimates while free cash flow stayed positive.
Clarivate bought back $75 million of 2028 bonds and cut first-half debt $218 million.

What critics are saying

Q2 2026 revenue fell 5.5%, and organic revenue declined 1.5% despite AI launches.
The $221.7 million goodwill impairment proves the Life Sciences exit destroyed reported earnings.
Eastern District of New York securities litigation remains open through discovery, extending management distraction.

What makes Clarivate unique

May 6, 2026, Web of Science Research Intelligence paired curated data with academic AI.
Clarivate Nexus launched January 22, 2026, embedding library content inside students' existing AI tools.
IPOne and Cortellis agentic AI automate patent, trademark, and drug-development workflows for subscribers.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options
Flexible Work Hours
Remote Work Options

Growth & Insights and Company News

6 month growth

1 year growth

35%

2 year growth

35%

Yahoo Finance

Nov 2nd, 2026

Clarivate brings CompuMark trademark data into Microsoft Copilot via IPOne

Clarivate Plc will bring its CompuMark trademark data into Microsoft Copilot through IPOne, a connector that lets intellectual property (IP) professionals use the data inside AI-powered workflows. The company announced the move in London on November 2, 2026. IPOne lets users query and analyse trademark intelligence through natural language, purpose-built AI agents, and tools such as Copilot. Clarivate calls it the intelligence infrastructure for AI-powered IP decisions. Simon Webster, Clarivate's president of intellectual property, said: "Trusted AI starts with trusted data." Clarivate is developing IPOne with corporate IP teams at 15 Fortune 500 companies and leading law firms.

MarketBeat

Oct 29th, 2026

Clarivate (NYSE:CLVT) stock falls 7.7% - should you Sell?

Clarivate (NYSE:CLVT) stock falls 7.7% - should you Sell? October 29, 2026 Key points. * Clarivate shares fell 7.7% to approximately $1.63, with trading volume well below its average. The stock is trading below both its 50-day and 200-day moving averages. * Analyst sentiment is cautious: the consensus rating is "Reduce", with one Buy, four Hold, and three Sell ratings; the consensus price target is $3.02. * Clarivate narrowly beat quarterly earnings expectations, but revenue declined 5.5% year over year and the company posted a negative net margin. Insider activity was mixed, with one director selling 2.49 million shares while another bought 250,000 shares. * MarketBeat previews top five stocks to own in November. Clarivate PLC (NYSE:CLVT - Get Free Report) shares were down 7.7% on Thursday. The company traded as low as $1.64 and last traded at $1.6250. Approximately 1,889,026 shares traded hands during trading, a decline of 68% from the average daily volume of 5,983,443 shares. The stock had previously closed at $1.76. Analyst upgrades and downgrades. Several research firms have recently commented on CLVT. Stifel Nicolaus decreased their price target on shares of Clarivate from $6.00 to $5.00 and set a "buy" rating on the stock in a research note on Thursday, July 30th. William Blair lowered shares of Clarivate to a "market perform" rating in a research note on Thursday, October 15th. Barclays lowered their price objective on shares of Clarivate from $2.50 to $2.00 and set an "underweight" rating for the company in a research report on Thursday, July 30th. Wall Street Zen cut shares of Clarivate from a "buy" rating to a "hold" rating in a report on Saturday, August 1st. Finally, The Goldman Sachs Group cut their price objective on shares of Clarivate from $2.90 to $2.60 and set a "neutral" rating on the stock in a research report on Thursday, July 30th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Reduce" and a consensus price target of $3.02. Clarivate stock performance. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.93. The stock has a market cap of $1.06 billion, a P/E ratio of -3.18 and a beta of 1.40. The stock has a 50 day simple moving average of $1.83 and a 200 day simple moving average of $2.25. Discover more MarketBeat All Access MarketBeat Research Tools Clarivate (NYSE:CLVT - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.01. Clarivate had a positive return on equity of 9.15% and a negative net margin of 13.84%. The company had revenue of $587.30 million during the quarter, compared to analysts' expectations of $589.73 million. During the same quarter in the prior year, the firm posted $0.18 earnings per share. The business's quarterly revenue was down 5.5% on a year-over-year basis. On average, equities analysts expect that Clarivate PLC will post 0.67 earnings per share for the current year. Insiders place their bets. In other news, Director Andrew Snyder sold 2,489,618 shares of the stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $1.94, for a total value of $4,829,858.92. Following the transaction, the director owned 3,856,597 shares of the company's stock, valued at $7,481,798.18. This represents a 39.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Kenneth L. Cornick bought 250,000 shares of the stock in a transaction dated Friday, August 7th. The stock was bought at an average cost of $1.85 per share, with a total value of $462,500.00. Following the purchase, the director owned 2,000,000 shares in the company, valued at $3,700,000. The trade was a 14.29% increase in their position. The SEC filing for this purchase provides additional information. Insiders own 22.88% of the company's stock. Hedge funds weigh in on Clarivate. A number of hedge funds have recently bought and sold shares of CLVT. First Trust Advisors LP boosted its stake in shares of Clarivate by 10.3% during the first quarter. First Trust Advisors LP now owns 5,522,601 shares of the company's stock valued at $13,972,000 after purchasing an additional 516,418 shares during the period. Empowered Funds LLC boosted its holdings in shares of Clarivate by 418.6% in the first quarter. Empowered Funds LLC now owns 2,015,829 shares of the company's stock valued at $5,100,000 after purchasing an additional 1,627,159 shares during the period. Bank of New York Mellon Corp grew its stake in Clarivate by 1.3% in the first quarter. Bank of New York Mellon Corp now owns 1,845,148 shares of the company's stock worth $4,668,000 after purchasing an additional 24,257 shares in the last quarter. KBC Group NV purchased a new position in Clarivate during the 1st quarter worth $4,118,000. Finally, Arrowstreet Capital Limited Partnership bought a new stake in Clarivate during the 1st quarter valued at $3,342,000. Institutional investors own 85.72% of the company's stock. About Clarivate. Clarivate Plc NYSE: CLVT provides analytics, data, and workflow solutions to organizations in academia, government, research, life sciences, and intellectual property. Its offerings are designed to help customers evaluate research, manage information, accelerate innovation, and support strategic decision-making. The company's products include Web of Science research databases and citation analytics, InCites research evaluation tools, Derwent innovation and patent intelligence services, and Cortellis life sciences and drug-development information. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Clarivate, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list. While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys. The space race is growing fast, and you don't have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important. Continue following MarketBeat

MarketScreener

Oct 15th, 2026

Sterne, Kessler, Goldstein & Fox and Clarivate plc announce partnership to develop ai-enhanced patent workflow solutions.

Sterne, Kessler, Goldstein & Fox and Clarivate plc announce partnership to develop ai-enhanced patent workflow solutions. Published on 10/15/2026 at 02:50 pm EDT S&P Capital IQ Sterne, Kessler, Goldstein & Fox announced a co-development partnership with Clarivate Plc to develop AI-enhanced patent workflow solutions. Together, the organizations will develop practical, future-ready capabilities that help teams transform technical, legal and portfolio data into actionable intelligence? enabling them to work more efficiently, make better-informed decisions and connect information across the patent lifecycle. This collaboration marks the beginning of a broader effort to develop next-generation capabilities for IP professionals. The first phase will focus on enhancing the patent drafting workflow, helping practitioners access relevant insights more seamlessly within Clarivate?s Rowan Patents, with an initial release targeted for the first half of 2027. (C) S&P Capital IQ - 2026

Clarivate

Sep 24th, 2026

Clarivate Completes Acquisition of CPA Global to Form a Global Intellectual Property Powerhouse

- Creates end-to-end solution covering the entire intellectual property, science and innovation lifecycle - Clarivate reaffirms standalone 2020 financial outlook Clarivate Plc (NYSE: CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today the completion of the previously announced acquisition of CPA Global, creating an intellectual property ("IP") powerhouse. "This is an exciting day for our company as we unite with CPA Global to offer our combined global customer base a more comprehensive suite of IP related products and services," said Jerre Stead, Executive Chairman and CEO of Clarivate. "With our joint resources and exceptional people, we are well positioned to accelerate the ways in which organizations can more effectively identify new opportunities, avoid risks, and act more efficiently throughout the innovation lifecycle." Simon Webster, formerly CEO of CPA Global and now Executive Advisor to the CEO at

SaasRise

Aug 17th, 2026

AI-Driven SaaS earnings power Tech stock upswing.

AI-Driven SaaS earnings power Tech stock upswing. SaasRise - Aug 17, 2026 AI-centric SaaS companies such as Doximity and Clarivate reported robust earnings and raised guidance, helping lift software stocks this month. The earnings beat highlights growing demand for AI-enhanced workflow tools and data-intelligence platforms. Why it matters. The strong earnings from AI-centric SaaS firms illustrate a shift in the software market: AI is no longer a peripheral add-on but a core growth engine. High net-revenue retention and accelerated bookings indicate that customers are willing to pay premium prices for AI-enhanced productivity, creating defensible revenue streams and higher expansion rates. For investors, these results validate higher multiples for AI-native SaaS companies, while for operators they highlight the strategic imperative to embed AI deeply into product and GTM strategies. Moreover, the rebound in software equities suggests that the market is re-pricing risk around AI adoption. Companies that can demonstrate measurable AI-driven ROI are likely to capture a larger share of the growing enterprise spend on automation and data intelligence, reinforcing competitive moats and fueling further valuation upside. Key points. * Doximity Q1 revenue $156.6M (+7% YoY) and raised FY2027 guidance to $671-$681M * Clarivate Q2 revenue $257.5M (+6.6% YoY) with bookings $30M ACV, 150% YoY growth * Both firms reported net-revenue retention above 100%, indicating strong expansion revenue * AI-driven product launches (Doximity AI search, Clarivate claims-intelligence) are central to growth * Tech market sentiment turned positive, with Nasdaq 100 futures up 0.2% and S&P 500 hitting fresh highs Analysis. The earnings surge from Doximity and Clarivate marks a inflection point for AI-enabled SaaS. Historically, AI has been a differentiator for a subset of high-growth software firms, but the current wave shows it becoming a baseline expectation for enterprise productivity tools. This shift mirrors the early 2010s transition when cloud infrastructure moved from a cost-center to a strategic asset; today, AI is the new strategic layer that drives both top-line expansion and pricing power. From a competitive dynamics perspective, firms that have built AI into the core of their platforms - rather than bolting it on - are achieving higher gross margins and NRR, as seen with Doximity's 87.5% non-GAAP gross margin and Clarivate's 60.5% adjusted EBITDA margin. This suggests that AI-native architectures enable more efficient scaling of compute resources and better data capture, which in turn fuels cross-sell and upsell opportunities. Companies still relying on legacy SaaS models without AI integration may find themselves pressured on pricing and churn. Looking forward, the market will likely reward firms that can demonstrate concrete AI ROI, such as reduced time-to-insight or measurable cost savings for customers. As AI compute costs normalize, the margin upside could be significant, especially for platforms that can monetize AI as a separate subscription tier. Investors should watch for guidance on AI-specific ARR and the pace of AI-driven expansion revenue, while operators must prioritize data hygiene, model governance, and seamless UX to sustain the current momentum.